TīmeklisRapid Novor成功获得融资的背后,是公司连续五年的快速发展。 总部坐落于加拿大滑铁卢的Rapid Novor,是全球领先的抗体测序公司,团队专注于基于质谱的蛋白质组学领域,开发了无需细胞系或DNA,直接对抗体蛋白质进行测序的技术(Antibody protein de novo sequencing)。 Tīmeklis2024. gada 30. jūn. · Rapid Novor曾于2024年7月完成凯风创投独家投资的500万美元A轮融资,新一轮融资已经接近close,所募集资金将主要用于在中国开展骨髓瘤相关临床试验,开发自身免疫疾病液体活检等新的临床诊断产品,以及拓展科研服务领域多抗蛋白 …
Careers at Rapid Novor
Tīmeklis2024. gada 28. jūl. · Rapid Novor Inc., the world's leader in antibody protein sequencing using mass spectrometry, announced today that it has secured a $5 million US dollar Series A round of financing led by Co-Win Venture. The investment will accelerate the company’s growth in technological and clinical development toward the company’s … TīmeklisRapid Novor Inc. is an equal opportunity employer. We do not discriminate based on ancestry, place of origin, citizenship status, ethnicity, religion, creed, disability, … hyvee se 14th park
蛋白从头测序新突破,Rapid Novor实现世界首例多抗蛋白全序列 …
TīmeklisRapid Novor 公司是抗体蛋白质测序技术的全球领导者。. 团队专注于基于质谱的蛋白质组学领域,开发了直接对抗体蛋白质进行测序的技术,无需细胞系或者DNA。. 公司 … Tīmeklis2024. gada 2. jūl. · 导读. 近日,凯风创投A轮独家投资企业Rapid Novor成为世界首个成功完成多克隆抗体蛋白的全序列直接测序的团队。. 未来几年,Rapid Novor将继续 … Tīmeklis2024. gada 15. nov. · Consequently, we performed a pilot study to assess the use of clonotypic MS-based MRD testing using the EasyM system (Rapid Novor, Kitchener, ON). We retrospectively identified a subset of patients in our institutional tissue bank who met the following criteria: 1) IgG multiple myeloma, 2) M-protein ≥0.5 g/dL by … molly thomas doctor lafayette la